Format

Send to

Choose Destination
Recenti Prog Med. 2011 Dec;102(12):461-7. doi: 10.1701/998.10857.

[The progression from hypertension to congestive heart failure].

[Article in Italian]

Author information

1
Cattedra e Struttura Complessa di Cardiologia, Dipartmento di Medicine Clinica e Molecolare, Sapienza Università di Romà.

Abstract

Arterial hypertension still represents one of the major modifiable risk factors for cardiovascular and renal disease. Solid evidences are available demonstrating the large and significant benefits deriving from blood pressure lowering therapies in terms of reduced incidence of major cardiovascular events, including myocardial infarction, ischemic stroke and cardiovascular death. It should be also noted, however, that hypertensive patients are at increased risk of developing congestive heart failure, being this risk substantially independent by the concomitant presence of left ventricular hypertrophy or dysfunction. Indeed, it has been demonstrated that blood pressure reduction and control significantly reduce the risk of developing congestive heart failure. In particular, several recent meta-analyses have demonstrated that the use of diuretics and renin-angiotensin system blockers is superior to calcium-antagonists and beta-blockers in terms of prevention of new-onset heart failure. The present paper overviews the main pathophysiological aspects of the progression from arterial hypertension to congestive heart failure and the potential therapeutic interventions able to reduce or prevent this progression.

PMID:
22258189
DOI:
10.1701/998.10857
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Il Pensiero Scientifico Editore
Loading ...
Support Center